REVVITY, INC Contract Liability (Deferred Revenue)
REVVITY, INC (RVTY) had Contract Liability (Deferred Revenue) of $20.02 million as of 2024-09-29, per its 10-Q filed 2024-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2024-11-06
- 2024-09-29: Contract with Customer, Liability, Current $20.02M.
- 2024-06-30: Contract with Customer, Liability, Current $20.37M.
- 2024-03-31: Contract with Customer, Liability, Current $22.68M.
- 2023-12-31: Contract with Customer, Liability, Current $22.50M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2024-09-29 | $20.02M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $20.37M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $22.68M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $22.50M 10-Q · filed 2024-11-06 | |
| 2023-10-01 | $24.31M 10-Q · filed 2023-11-07 | |
| 2023-07-02 | $19.85M 10-Q · filed 2023-08-09 | |
| 2023-04-02 | $21.97M 10-Q · filed 2023-05-12 | |
| 2023-01-01 | $30.13M 10-K · filed 2024-02-27 | |
| 2022-10-02 | $34.21M 10-Q · filed 2022-11-14 | |
| 2022-07-03 | $50.94M 10-Q · filed 2022-08-09 | |
| 2022-04-03 | $171.87M 10-Q · filed 2022-05-10 | |
| 2022-01-02 | $184.90M 10-K · filed 2023-03-01 | $201.07M 10-K · filed 2022-03-03 |
| 2021-10-03 | $209.60M 10-Q · filed 2021-11-09 | |
| 2021-07-04 | $230.70M 10-Q · filed 2021-08-10 | |
| 2021-04-04 | $221.00M 10-Q · filed 2021-05-11 | |
| 2021-01-03 | $238.12M 10-K · filed 2022-03-03 | $238.10M 10-K · filed 2021-03-02 |
| 2020-10-04 | $35.00M 10-Q · filed 2020-11-10 | |
| 2020-07-05 | $35.10M 10-Q · filed 2020-08-11 | |
| 2020-04-05 | $32.10M 10-Q · filed 2020-05-12 | |
| 2019-12-29 | $29.94M 10-K · filed 2022-03-03 | $29.90M 10-K · filed 2020-02-25 |
| 2019-09-29 | $26.20M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $31.60M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $30.30M 10-Q · filed 2019-05-07 | |
| 2018-12-30 | $30.80M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $26.30M 10-Q · filed 2018-11-06 | |
| 2018-07-01 | $26.90M 10-Q · filed 2018-08-07 | |
| 2018-04-01 | $33.20M 10-Q · filed 2018-05-08 | |
| 2018-01-01 | $29.00M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |